Skip to Navigation | Skip to Content

Upper link For Anonymous users

Log in

September 13, 2011
Upper link

Advanced Search

September 13, 2011
Upper link

View Cart

September 13, 2011
Upper link

Contact Us

September 13, 2011

Medication Safety Committee

Overview

Medication Safety Committee

November 25, 2009 BJ Bartleson

The Medication Safety Committee coordinates various organizations and agencies addressing medication safety issues.

CHA News Article

Warning, Recommendations Emphasize Use of Diluted Acetic Acid

May 1, 2013 David Perrott, MD, DDS BJ Bartleson

The CHA Medication Safety Committee reminds all health care providers about the Institute for Safe Medication Practices’ (ISMP) warning regarding the consequences of accidental application of “glacial” acetic acid (≥ 99.5 percent) to skin or mucous membranes. Because inadvertent application of the corrosive chemical can lead to serious and permanent damage, the ISMP urges health care providers to take immediate steps to ensure only diluted forms are used in patient care. The complete warning and seven immediate recommendations to prevent serious error are available at www.ismp.org/nan/files/20130121.pdf.

General information

CHA Medication Safety Guidelines for Anticoagulants

Image of CHA Medication Safety Guidelines for Anticoagulants
January 25, 2013 BJ Bartleson

Anticoagulation is a high risk therapy involving complex dosing and stringent monitoring as well as ensuring patient adherence with outpatient therapy.Citing a number of high profile errors, the Joint Commission (TJC) issued a Sentinel Event alert in September 2008 alerting clinicians to the risks related to these potentially life-saving drugs.They also introduced a National Patient Safety Goal requiring organizations to implement processes for reducing the likelihood of patient harm associated with the use of anticoagulation therapy.

The CHA Medication Safety Committee has created

General information

CHA Medication Safety Guidelines for Fentanyl Patch

Image of CHA Medication Safety Guidelines for Fentanyl Patch
October 14, 2011 BJ Bartleson

Despite warnings from the Food and Drug Administration, manufacturers and various patient safety agencies, fentaNYL transdermal patches continue to be prescribed inappropriately to treat patients with acute pain who are not opioid tolerant. CDPH has issued several Immediate Jeopardy administrative penalties for inappropriate use of fentaNYL transdermal patches.

Commands